This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heinrichs, C. Articles by Baron, J. Search for Related Content PubMed PubMed Citation Articles by Heinrichs, C. Articles by Baron, J.

Effects of Fasting on the Growth Plate: Systemic and Local Mechanisms¹

Developmental Endocrinology Branch, NICHD, NIH, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Jeffrey Baron, M.D., National Institutes of Health, Building 10, Room 10N262, 10 Center Drive MSC 1862, Bethesda, Maryland 20892-1862. E-mail: Baronj{at}cc1.nichd.nih.gov

Inadequate caloric intake inhibits longitudinal bone growth. This study was designed to investigate the mechanisms responsible for this suppression of growth plate function, focusing on the roles of systemic and local insulin-like growth factor 1 (IGF-1). Five week-old male rabbits were fasted for 48 h. Fasting significantly decreased proximal tibial growth velocity and growth plate width (both proliferative and hypertrophic zones). During the fast, systemic IGF-1 production was down-regulated. Serum IGF-1 levels and hepatic IGF-1 messenger RNA (mRNA) levels decreased despite increased GH levels. Serum levels of GH binding protein (a circulating fragment of the GH receptor) and hepatic GH receptor mRNA levels were not significantly changed. In contrast, the local, growth plate IGF-1 system appeared to be up-regulated. Growth plate GH receptor mRNA and IGF-1 mRNA levels were both increased during fasting.

We conclude that, in the rabbit, fasting induces a rapid depletion of growth plate chondrocytes and inhibition of longitudinal bone growth. These effects appear to be mediated by systemic endocrine mechanisms; circulating IGF-1 levels are diminished because of hepatic resistance to GH. In contrast, the local, paracrine IGF-1 system in growth plate does not appear to contribute to the growth inhibition but instead appears to be up-regulated by fasting.

This article has been cited by other articles:

				K. C. Lasseter, L. Shaughnessy, D. Cummings, J. C. Pezzullo, W. Wargin, R. Gagnon, J. Oliva, and G. Kosutic Ghrelin Agonist (TZP-101): Safety, Pharmacokinetics and Pharmacodynamic Evaluation in Healthy Volunteers: A Phase I, First-in-Human Study J. Clin. Pharmacol., February 1, 2008; 48(2): 193 - 202. [Abstract] [Full Text] [PDF]

				J. Baron Growth Hormone Therapy in Childhood: Titration Versus Weight-Based Dosing? J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2436 - 2438. [Full Text] [PDF]

				T. C. R. Prickett, G. K. Barrell, M. Wellby, T. G. Yandle, A. M. Richards, and E. A. Espiner Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1395 - E1400. [Abstract] [Full Text] [PDF]

				R. M. Luque, Z. H. Huang, B. Shah, T. Mazzone, and R. D. Kineman Effects of leptin replacement on hypothalamic-pituitary growth hormone axis function and circulating ghrelin levels in ob/ob mice Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E891 - E899. [Abstract] [Full Text] [PDF]

				R. M. Luque, S. Park, and R. D. Kineman Severity of the Catabolic Condition Differentially Modulates Hypothalamic Expression of Growth Hormone-Releasing Hormone in the Fasted Mouse: Potential Role of Neuropeptide Y and Corticotropin-Releasing Hormone Endocrinology, January 1, 2007; 148(1): 300 - 309. [Abstract] [Full Text] [PDF]

				G. Gat-Yablonski, T. Ben-Ari, B. Shtaif, O. Potievsky, O. Moran, R. Eshet, G. Maor, Y. Segev, and M. Phillip Leptin Reverses the Inhibitory Effect of Caloric Restriction on Longitudinal Growth Endocrinology, January 1, 2004; 145(1): 343 - 350. [Abstract] [Full Text] [PDF]

				O. Nilsson, J. Falk, E. M. Ritzen, J. Baron, and L. Savendahl Raloxifene Acts as an Estrogen Agonist on the Rabbit Growth Plate Endocrinology, April 1, 2003; 144(4): 1481 - 1485. [Abstract] [Full Text] [PDF]

				W. M. Naranjo, S. Yakar, M. Sanchez-Gomez, A. U. Perez, J. Setser, and D. LERoith Protein Calorie Restriction Affects Nonhepatic IGF-I Production and the Lymphoid System: Studies Using the Liver-Specific IGF-I Gene-Deleted Mouse Model Endocrinology, June 1, 2002; 143(6): 2233 - 2241. [Abstract] [Full Text] [PDF]

				N. Nagaya, M. Kojima, M. Uematsu, M. Yamagishi, H. Hosoda, H. Oya, Y. Hayashi, and K. Kangawa Hemodynamic and hormonal effects of human ghrelin in healthy volunteers Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1483 - R1487. [Abstract] [Full Text] [PDF]

				A.B. Ballinger, C. Camacho-Hubner, and N.M. Croft Growth failure and intestinal inflammation QJM, March 1, 2001; 94(3): 121 - 125. [Full Text] [PDF]

				A B Ballinger, O Azooz, T El-Haj, S Poole, and M J G Farthing Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis Gut, May 1, 2000; 46(5): 695 - 700. [Abstract] [Full Text] [PDF]

				R. J. Bollag, Q. Zhong, P. Phillips, L. Min, L. Zhong, R. Cameron, A. L. Mulloy, H. Rasmussen, F. Qin, K. H. Ding, et al. Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors Endocrinology, March 1, 2000; 141(3): 1228 - 1235. [Abstract] [Full Text] [PDF]